Lisa M. Ford

Pediatric Neurology

90 Bergen St
Newark, NJ 07103

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Self-reported sleep quality and longitudinal amyloid burden in clinically unimpaired adults from the AMYPAD PNHS study.

Self-reported sleep quality and longitudinal amyloid burden in clinically unimpaired adults from the AMYPAD PNHS study.

Journal: Alzheimer's research & therapy

Published: February 05, 2026

A randomized, double-blind, placebo-controlled, time-to-event study of the efficacy and safety of JNJ-40411813 in combination with levetiracetam or brivaracetam in patients with focal onset seizures.

A randomized, double-blind, placebo-controlled, time-to-event study of the efficacy and safety of JNJ-40411813 in combination with levetiracetam or brivaracetam in patients with focal onset seizures.

Journal: Epilepsia

Published: July 22, 2025

Amyloid-PET imaging predicts functional decline in clinically normal individuals.

Amyloid-PET imaging predicts functional decline in clinically normal individuals.

Journal: Alzheimer's research & therapy

Published: February 01, 2024

Recruitment of pre-dementia participants: main enrollment barriers in a longitudinal amyloid-PET study.

Recruitment of pre-dementia participants: main enrollment barriers in a longitudinal amyloid-PET study.

Journal: Alzheimer's research & therapy

Published: May 30, 2023

The amyloid imaging for the prevention of Alzheimer's disease consortium: A European collaboration with global impact.

The amyloid imaging for the prevention of Alzheimer's disease consortium: A European collaboration with global impact.

Journal: Frontiers in neurology

Published: October 07, 2022

Dementia, Subtype of Seizures, and the Risk of New Onset Seizures: A Cohort Study.

Dementia, Subtype of Seizures, and the Risk of New Onset Seizures: A Cohort Study.

Journal: Journal of Alzheimer's disease : JAD

Published: April 12, 2021

The effects of JNJ-39393406 a positive allosteric nicotine modulator on mood and cognition in patients with unipolar depression: A double-blind, add-on, placebo-controlled trial.

The effects of JNJ-39393406 a positive allosteric nicotine modulator on mood and cognition in patients with unipolar depression: A double-blind, add-on, placebo-controlled trial.

Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

Published: January 15, 2021

Quantitative amyloid PET in Alzheimer's disease: the AMYPAD prognostic and natural history study.

Quantitative amyloid PET in Alzheimer's disease: the AMYPAD prognostic and natural history study.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: August 26, 2019

Initial Cross-Over Test of A Positive Allosteric Modulator of Alpha-7 Nicotinic Receptors to Aid Cessation in Smokers With Or Without Schizophrenia.

Initial Cross-Over Test of A Positive Allosteric Modulator of Alpha-7 Nicotinic Receptors to Aid Cessation in Smokers With Or Without Schizophrenia.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Published: August 28, 2017

Comprehensive review of visual defects reported with topiramate.

Comprehensive review of visual defects reported with topiramate.

Journal: Clinical ophthalmology (Auckland, N.Z.)

Published: June 06, 2017

Is uveitis associated with topiramate use? A cumulative review.

Is uveitis associated with topiramate use? A cumulative review.

Journal: Clinical ophthalmology (Auckland, N.Z.)

Published: August 19, 2016

Age-Stratified Prevalence of Mild Cognitive Impairment and Dementia in European Populations: A Systematic Review.

Age-Stratified Prevalence of Mild Cognitive Impairment and Dementia in European Populations: A Systematic Review.

Journal: Journal of Alzheimer's disease : JAD

Published: September 25, 2015

Showing 1-12 of 24

Last Updated: 09/26/2026